The Co-Expression of Programmed Death-Ligand 1 (PD-L1) in Untreated EGFR-Mutated Metastatic Lung Adenocarcinoma

Epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitor (TKI) is the standard first-line therapy for metastatic lung adenocarcinoma harboring sensitive EGFR mutations. Tumor surface programmed death-ligand 1 (PD-L1) is expressed in some metastatic EGFR-mutated lung adenocarcinoma, but its...

Descripción completa

Detalles Bibliográficos
Autores principales: Hsu, Ping-Chih, Wang, Chih-Wei, Kuo, Scott Chih-Hsi, Lin, Shu-Min, Lo, Yu-Lun, Huang, Allen Chung-Cheng, Chiu, Li-Chung, Yang, Cheng-Ta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7167989/
https://www.ncbi.nlm.nih.gov/pubmed/32092879
http://dx.doi.org/10.3390/biomedicines8020036

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7167989/
https://www.ncbi.nlm.nih.gov/pubmed/32092879
http://dx.doi.org/10.3390/biomedicines8020036

Ejemplares similares